肝细胞癌术后甲磺酸仑伐替尼治疗相关急性心肌梗死1例
A case of lenvatinib mesylate associated with acute myocardial infarction in postoperative hepatocellular carcinoma
李娜 1欧春霞 1李琳1
作者信息
- 1. 昆明医科大学第一附属医院心内科(昆明,650032)
- 折叠
摘要
本文报道1例63岁肝细胞癌术后的女性患者,采用甲磺酸仑伐替尼治疗21个月后出现药物相关的急性非ST段抬高型心肌梗死.提示在长期使用甲磺酸仑伐替尼等抗血管生成药物治疗时,需密切监测是否有急性冠状动脉血栓事件发生,以便及时发现和处理.
Abstract
This article reports a 63-year-old female patient with hepatocellular carcinoma after surgery who developed drug-related acute non-ST segment elevation myocardial infarction after 21 months of treatment with le-nvatinib mesylate.It is important to closely monitor the occurrence of acute coronary thrombosis events during long-term use of antiangiogenic drugs such as lenvatinib mesylate,and timely detection and management of ad-verse reactions can effectively reduce the harm of lenvatinib mesylate related side effect.
关键词
急性心肌梗死/甲磺酸仑伐替尼/肝癌Key words
acute myocardial infarction/lenvatinib mesylate/hepatoma引用本文复制引用
基金项目
云南省科学技术厅-昆明医科大学应用基础研究联合专项资金(2019FE001-056)
云南省心脑血管疾病临床医学中心建设项目(ZX2019-03-01)
昆明医科大学研究生创新基金(2023S283)
出版年
2024
NETL
NSTL
万方数据